Dr. Boin is a physician-scientist with extensive experience in the diagnosis and treatment of scleroderma and other fibrosing skin disorders. His research is focused on the genetic risk of scleroderma and the biology of immune cells involved in the pathogenesis of this disease. He has been investigating the role of effector T cells in driving pro-inflammatory and pro-fibrotic pathways leading to scleroderma-specific tissue damage. In partnership with the NIH and the Johns Hopkins Scleroderma Center, he currently coordinates the Genome Research in African American Scleroderma Patients (GRASP) study, a consortium involving 25 U.S. academic centers new disease-associated susceptibility genes in African American patients affected by scleroderma using next-generation sequencing platforms. His goal is to identify novel and reliable tools to investigate the causes of scleroderma, effectively measure disease activity, monitor treatments and help predict clinical outcomes in scleroderma patients.